Methionine is activated to S-adenosylmethionine (SAM), the universal methyl donor for biosynthetic reactions. Cysteine is synthesized from serine and homocysteine and is a precursor for glutathione, taurine, and coenzyme A. Homocysteine is remethylated to methionine or converted to cysteine, linking these pathways to one-carbon metabolism.
From your study of amino acid degradation, you know that each amino acid has its own catabolic fate. The sulfur-containing amino acids — methionine and cysteine — are special because their metabolism is not primarily about energy extraction. Instead, these pathways exist to manage the sulfur atom and, critically, to generate S-adenosylmethionine (SAM), the most important methyl donor in all of biochemistry.
The methionine cycle begins when methionine reacts with ATP in an unusual reaction catalyzed by methionine adenosyltransferase (MAT). The entire adenosyl group of ATP is transferred to the sulfur atom, producing SAM — a molecule with a high-energy sulfonium ion that makes its methyl group highly reactive. SAM donates this methyl group to an enormous variety of acceptors: DNA (for epigenetic regulation), norepinephrine (to make epinephrine), guanidinoacetate (to make creatine), and phosphatidylethanolamine (to make phosphatidylcholine), among many others. After donating its methyl group, SAM becomes S-adenosylhomocysteine (SAH), which is hydrolyzed to homocysteine and adenosine.
Homocysteine sits at a critical metabolic branch point. It can be remethylated back to methionine — either by methionine synthase (using N⁵-methyl-THF as the methyl donor, requiring vitamin B₁₂) or by betaine-homocysteine methyltransferase (using betaine from choline). Alternatively, homocysteine can be committed irreversibly to the transsulfuration pathway: cystathionine β-synthase (requiring vitamin B₆) condenses homocysteine with serine to form cystathionine, which is then cleaved to yield cysteine. This makes cysteine a conditionally essential amino acid — the body can synthesize it, but only if methionine intake is adequate.
The clinical relevance of this pathway is substantial. Elevated plasma homocysteine (hyperhomocysteinemia) is associated with cardiovascular disease, neural tube defects, and cognitive decline. Deficiencies in vitamins B₆, B₁₂, or folate all impair homocysteine disposal and raise its levels, which is why these vitamins are so tightly linked to cardiovascular health. Meanwhile, cysteine feeds into glutathione synthesis — the cell's primary antioxidant defense — and provides sulfur for taurine, iron-sulfur clusters, and the pantetheine moiety of coenzyme A. Understanding this network reveals why sulfur amino acid metabolism sits at the intersection of methylation biology, antioxidant defense, and one-carbon metabolism.